Next generation biologicals – are we there yet?

Next generation biologicals – are we there yet?

AllergoOncology: Predicting and preventing toxicities in patients with solid cancers treated with IgE class antibodies recognising tumour antigens

Suppression of IgE production in primary human B-cells using a novel anti-IgE molecule

Lirentelimab Reduces Levels of Inflammatory Cytokines in Tear Fluid From Patients With Allergic Conjunctivitis